Metrion Biosciences Blog background 2 scaled

ConnectIONS

ConnectIONS is Metrion Biosciences’ collection of blogs, articles, interviews and insights from our team and distinguished guests. They share their thoughts, ideas, strategies, and lessons to deliver high-quality ion channel drug discovery.

John Ridley PhD

FEATURED POST

Improving Cardiac Safety Testing Protocols

The International Council on Harmonization (ICH) S7B and E14 regulatory guidelines were introduced in 2005 to evaluate the proarrhythmic liability of new drugs. They were implemented in response to the discovery that inhibition of a cardiac potassium channel (encoded by hERG) is associated with prolongation of the QT interval and a potentially deadly arrhythmia, Torsades de Pointes.

Read more…

Written by John Ridley PhD

Latest Posts

  • Alex’s Story So Far…
    Written by Dr Alex Howarth Metrion Scientist Dr Alexander Howarth summarises below his undergraduate and postgraduate studies and how he came to join Metrion Biosciences. “In 2015, I graduated from the University of Sheffield with a […]
  • Pete’s Path into Electrophysiology
    Written by Dr Peter Matthews Metrion Scientist Dr Peter Matthews summarises below his path into electrophysiology and recounts his experiences during his undergraduate and postgraduate studies and beyond. “I first became interested in the physiology and […]
  • Discovery of KNa1.1 channel inhibitors – an account of Metrion’s first webinar
    Written by Marc Rogers PhD and Sophie Rose PhD Metrion’s first “Ion channel drug discovery” webinar  Metrion Biosciences’ inaugural ion channel webinar took place at the end of June and featured a presentation by Dr Jon Lippiat, […]
  • The Ionic Inspiration of Venomtech – by Steve Trim
    Our guest blog, written by longstanding Friend and Collaborator Steve Trim, CSO and Founder of Venomtech is presented below. An early career at Pfizer, Sandwich “Why spider man is joining forces with ion man” is a […]
  • The Drug Discovery for Ion Channels XXII Satellite Meeting
    Written by Marc Rogers PhD and Sophie Rose PhD A global pandemic wasn’t going to stand in our way Nothing was going to prevent this annual gathering of ion channel enthusiasts and drug discovery professionals from […]
  • SARS-CoV-2 Drug Discovery: Targeting Viral Ion Channels
    Written by Dr Marc Rogers Introduction Ion channels are well validated drug discovery targets based on their widespread distribution in the human body and involvement in many critical activities within the brain, heart, smooth muscle and […]
  • Charlotte’s Patch Clamp Journey So Far…
    Written by Dr Charlotte Hill Metrion Scientist Dr Charlotte Hill explains how she first discovered the wonderful world of patch clamp electrophysiology and how she came to write the chapter “An Introduction to Patch Clamp Recording” […]
  • Metrion and Grünenthal extend Ion Channel Research Agreement
    Written by the Editor Metrion Biosciences have had a longstanding relationship providing drug discovery research services to Grünenthal GmbH, a privately owned pharmaceutical company and global leader in pain management and related diseases. Grünenthal develop medication […]
  • An Interview with Damian Bell
    Written by Artem Kondratskyi Introducing Damian Bell: as a new member of the team at Metrion we are using an abridged version of an interview by Artem Kondratskyi for ionchannellibrary.com. A big thank you to Artem for […]
  • Metrion welcomes new sales and marketing intern, Anna
    Written by Anna Mikhailova My name is Anna Mikhailova. I recently started my internship in Sales and Marketing at Metrion Biosciences. I was born in Moscow, Russia, and moved to study in the UK when I […]
  • Improving Cardiac Safety Testing Protocols
    Written by John Ridley PhD The regulatory guidelines The International Council on Harmonization (ICH) S7B and E14 regulatory guidelines were introduced in 2005 to evaluate the proarrhythmic liability of new drugs. They were implemented in response […]
  • Metrion is open for business
    Written by the Editor Metrion Biosciences is open to discuss your ion channel drug discovery and safety profiling requirements via info@metrionbiosciences.com.    In response to the global COVID-19 outbreak, and to help us to safeguard the health and […]
  • Metrion’s CEO reflects on participation in Goldman Sachs’ 10,000 Small Businesses UK
    Written by Andrew Southan PhD During the second half of 2019 Metrion’s CEO Andy Southan spent three months on the Goldman Sachs 10,000 Small Businesses programme. In this blog he reflects on the aims and content […]
  • Why Metrion’s CSO spent 35 years unlocking the potential of ion channels for drug discovery
    Interview with Dr Marc Rogers Thank you to the ELRIG Committee and to BioStrata for allowing us to share the below content on our website. The British Pharmacological Society (BPS) ran a special symposium at the ELRIG Drug Discovery 2019 conference yesterday, […]
  • Nav1.5(Late) Cardiac Safety Assay on QPatch
    Written by the Editor The Metrion Biosciences team have recently produced a second application note in collaboration with Sophion Bioscience, describing the use of a ∆KPQ LQT3 mutant to create and validate a Nav1.5 (Late) cardiac […]
  • Opportunities for Ion Channel Targeting Antibodies: Current Landscape and Pipeline
    External Speaker Series presentation featuring Dr Catherine Hutchings Metrion Biosciences’ tenth External Speaker Series presentation featured Dr Catherine Hutchings, a highly experienced biologics drug discovery researcher and independent consultant. Dr Hutchings’ presentation included an overview of […]
  • An Interview with Professor Nikita Gamper
    Interview by the Editor Professor Nikita Gamper, the ninth contributor to Metrion Biosciences External Speaker Series, gives a perspective below regarding his ion channel research focus and collaboration activities with scientists from the Hebei Medical University, China.   […]
  • ELRIG: Advances in Cell Based Screening – Gothenburg, Sweden
    Review written by the Editor ELRIG is a not-for-profit organisation aiming to provide access to high level scientific content, promote innovation in drug discovery and provide networking platforms for the life science community. To implement this, ELRIG […]
  • Ion Channels in Drug Discovery XIX – Satellite event at BPS 2019
    Review written by the Editor Ion channels continue to rise in prominence in both academic and commercial areas. Metrion Biosciences, alongside Sophion Bioscience, Nanion Technologies, Evotec and SB Drug Discovery sponsored the “Ion Channels in Drug […]
  • A summary of the Sixth Cambridge Ion Channel Forum
    Review written by the Editor AstraZeneca and Metrion Biosciences again joined forces on April 9 to co-host the 6th Cambridge Ion Channel Forum, held at the Milstein building at Granta Park. The event has been a […]
  • An Interview with Professor Alistair Mathie
    Written by the Editor Professor Alistair Mathie, one of Metrion’s previous external speakers, gives a perspective below regarding his research into two pore domain potassium channels and his involvement in a collaborative project focused on the […]
  • Implementation of a kinetic hERG Assay Protocol Using QPatch 48
    Written by the Editor The Metrion Biosciences team recently produced an application note reporting the successful validation of the ‘Milnes’ voltage protocol for hERG screening using a QPatch 48 automated patch clamp (APC) assay platform. First […]
  • An Interview with Professor Gary Stephens
    Written by the Editor Professor Gary Stephens gives his perspective on his research into calcium channel modulation, cannabinoid-derived anti-epileptic agents; plus biologics and SUMOylation in the field of ion channel modulation. Calcium channels and synaptic transmission […]
  • Professor Trevor Jones: Disruptive Influences on Drug Discovery and Healthcare Delivery
    External Speaker Series presentation featuring Professor Trevor Jones Metrion Biosciences’ July 2018 External Speaker Event provided insight into the pitfalls of modern medicines discovery and the “disruptive influences” associated with drug discovery and development. The presentation […]
  • An Interview with Professor Annette Dolphin
    External Speaker Series presentation featuring Professor Annette Dolphin Professor Annette Dolphin, Metrion Biosciences Scientific Advisory Board member and seventh presenter in our external speaker series, gives her perspective on her research into neuronal voltage-dependent calcium channels. […]
  • An interview with Professor Mustafa Djamgoz
    External Speaker Series presentation featuring Professor Mustafa Djamgoz Professor Mustafa Djamgoz (Imperial College London), the sixth presenter in Metrion Biosciences External Speaker Series, provides some insight into his research into the role of ion channels in […]
  • Cambridge Ion Channel Forum (2018)
    Review written by the Editor Metrion Biosciences and AstraZeneca joined forces on Tuesday 8th May 2018 to co-host the fifth Cambridge Ion Channel Forum at Medimmune’s Milstein Building on Granta Park, Cambridge (UK). Established in 2011, with previous co-organisers including […]
  • Interactive Stem Cell Forum
    Review by the Editor Researchers gather for interactive forum Metrion Biosciences and Axol Bioscience joined forces on Wednesday 23rd May to co-host the 2018 “Interactive Stem Cell Forum” in Cambridge (UK). A meeting featuring a morning […]